hVEGF-IN-1
R1530
WAY-340935
Olinvacimab (Anti-VEGFR2 / KDR / CD309)
Parsatuzumab (Anti-EGFL7)
Icrucumab (Anti-VEGFR1 / FLT1)
Ranibizumab (Anti-VEGFA)
Ramucirumab (anti-VEGFR2)
Bevacizumab (anti-VEGF)
(20R)-Protopanaxadiol
Donafenib (Sorafenib D3)
BFH772
Dovitinib (TKI258) Lactate monohydrate
BAW2881 (NVP-BAW2881)
ODM-203
Lucitanib (E3810) hydrochloride
SU5402
Sorafenib (BAY 43-9006)
SKLB1002
Nastorazepide